# Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy?

> **NCT01542970** · NA · UNKNOWN · sponsor: **Ostergotland County Council, Sweden** · enrollment: 496 (estimated)

## Conditions studied

- Allergy
- Gastrointestinal Function

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Omega-3 fatty acids
- **DIETARY_SUPPLEMENT:** Refined coconut and peanut oil without L. reuteri
- **DIETARY_SUPPLEMENT:** L. reuteri

## Key facts

- **NCT ID:** NCT01542970
- **Lead sponsor:** Ostergotland County Council, Sweden
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 496 (ESTIMATED)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01542970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01542970, "Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy?". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01542970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*